Commentary: Aripiprazole: The Second Wave of the Second-generation Antipsychotics

Three cases are presented describing unique clinical responses to aripiprazole in comparison with other second-generation antipsychotics taken by each patient. One case involved an adverse reaction of problem gambling behavior, the second an enhanced antipsychotic response in delusional disorder, and the third a reversal of weight gain that occurred while the patient continued taking olanzapine. Aripiprazole was the first of a subgroup of atypical antipsychotics that are mixed agonists and antagonists of dopamine, likely contributing to unusual responses in some patients.

Source: Journal of Psychiatric Practice - March 1, 2019 Category: Psychiatry Tags: CLINICAL CASE DISCUSSIONS Source Type: research